Informatics-driven Quality by Design for Drug Development
The Pharmaceutical industry has been slow to adopt the regulatory Quality by Design (QbD) guidelines. However, leaner times are forcing Pharmas to change and optimize business practices. QbD focuses on better understanding the process and product attributes that affect product quality. A QbD strategy for Pharma supported by modern Informatics offers significant opportunities to lower compliance costs and improve product quality while delivering better therapeutic products, faster and at lower cost to patients. This whitepaper explores the Informatics journey and its role in driving QbD adoption within drug development.
Please complete the following form for access to the whitepaper.